Company / Revenue
RAPT Therapeutics, Inc. Revenue History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2023
5-year range
$0 / $5.0M
FY2020-FY2023
Trend
-100.0%
vs FY2022
Sector context
#147 of 152
Health Care
What the data says
Declined from $4M to $0 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 152
▼
Key checks
Key Insights
- RAPT Therapeutics, Inc.'s revenue has declined for 3 consecutive years.
- In FY2023, revenue decreased 100.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $1.5M | -60.0% |
| FY2021 | $3.8M | -24.4% |
| FY2020 | $5.0M | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026